Enhancing Protein Development with Active Learning-Assisted Directed Evolution
REGISTER NOW
Broadcast Date: Wednesday, October 23, 2024Time: 8:00 am PT, 11:00 am ET, 17:00 CEST
Directed Evolution (DE) is a method developed by Nobel laureate Frances Arnold to improve protein fitness for...
Your bathroom is a hidden haven of untapped viral biodiversity
A new study found over 600 different viruses in samples from showerheads and toothbrushes, with no two samples being the same.
Study: Phage communities in household-related biofilms correlate with bacterial hosts. Image Credit: ReaLiia/Shutterstock.com
...
Study uncovers mechanism of MX protein in fighting HIV-1 and herpes simplex virus
A group of researchers led by Xavier Saelens and Sven Eyckerman at the VIB-UGent Center for Medical Biotechnology discovered how a protein linked to the human immune system wards off HIV-1 and herpes simplex...
Researchers discover potential therapeutic approach for triple negative breast cancer
Triple negative breast cancer (TNBC) remains the most aggressive and deadly type of breast cancer, but new findings from cancer researchers at Brigham and Women's Hospital, a founding member of the Mass General Brigham...
Illumina Launches New MiSeq i100 Series with XLEAP Chemistry, RT Reagents
Weeks of teasers on social media noting that “Something big is coming. And it’s small,” have sparked a guessing game (and some patent searching) among NGS aficionados. But today, Illumina quelled the rumors with...
Parkinson’s Lewy Bodies Formed in Human Neuronal Stem Cells
Lewy bodies are a hallmark of Parkinson’s disease (PD) and other related neurological conditions. The presence of Lewy bodies in the brain is considered a “pathologic certainty” of Parkinson’s disease, but they can only...
USC’s Keck School of Medicine partners with StemCardia to advance heart failure treatment
The Keck School of Medicine of USC has launched a strategic collaboration with StemCardia, a biotechnology company, founded by a Keck School of Medicine faculty member, that develops cellular and genetic therapies to address heart...
StockWatch: BioAge, Orum Reflect Renewed Interest in IPOs
An uptick in initial public offering (IPO) filings in recent weeks suggests that the market for first-time biotech stocks is finally recovering after three years of sparse activity capped by share prices that had...
PacBio to commence first customer shipments of Revio long-read sequencing systems
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its first customer shipments of Revio long-read sequencing systems will commence on March 8, 2023. As previously announced, the Revio system features...
Engineered E. coli shows promise in cancer immunotherapy
Study title: Nonpathogenic E. coli displaying decoy-resistant IL18 demonstrate potent anti-tumor responses and boost CAR-NK cell therapy
Publication: Nature Biotechnology
Dana-Farber Cancer Institute authors: Rizwan Romee, MD, Shaobo Yang, Michal Sheffer, PhD, David Barbie, MD, Catherine Wu, MD, Robert J. Soiffer, MD, Jerome Ritz, MD
